Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

This Solicitation opportunity from Government of Canada was posted on March 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

RFP - Secondary Pandemic Influenza Vaccine (PIV) Readiness and Supply

Closed
WS4698221354Canada

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Government of Canada → Department of Public Works and Government ServicesView Agency

NAICS

N/A

Place of Performance

*Canada, CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

1 update
PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Amendment 1

Contract was updated

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Public Works and Government Services
View Agency Profile
Office AddressN/A
Contacts
Chan Lina (SPAC/PSPC) (elle-la / she-herPoint of Contact
contact@example.gov

Full Description

Show more
Canada has a requirement to establish a new Secondary Pandemic Influenza Vaccine (PIV) Readiness and Supply Contract(s) to access up to 25 million doses of PIV. The Contractor(s) must have and maintain a state of pandemic readiness and be able to supply an in?uenza vaccine (inclusive of adjuvant, if applicable) that is indicated for the active immunization of adults and children six (6) months of age and older and which demonstrates an acceptable level of safety and immunogenicity against the relevant pandemic in?uenza virus strain(s) identified by the World Health Organization (WHO). The full Request for Proposal (RFP) and attachments can only be accessed and downloaded when logged into your SAP Ariba account and have filled out your Government of Canada profile. The web link to login to SAP Ariba (or to register for an SAP Ariba account) can be found under the Bidding details tab. Additional details can be found on the Ariba Discovery Posting and the Notice of Proposed Procurement (NPP) here: https://discovery.ariba.com/rfx/23130346 .